Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Ritter

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Contemporary Clinical Trials|November 11, 2025
Trial of SiTes to IncreAse diversity in clinical TriaLs (TOTAL): A study protocol paperTenzin Yeshi Wangdak Yuthok, Anny D Rodriguez, Victor Ritter, et al.
Nature Communications|April 12, 2023
Antimicrobial exposure is associated with decreased survival in triple-negative breast cancerJulia D Ransohoff, Victor Ritter, Natasha Purington, et al.
JAMA Oncology|February 13, 2025
Endocrine Therapy Interruption, Resumption, and Outcomes Associated With Pregnancy After Breast CancerJulia D Ransohoff, Rebecca M Lewinsohn, James Dickerson, et al.
BMJ Public Health|July 7, 2025
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in BrazilJuliana Barros Verruck, Marco Antonio Moreira Puga, Roberto Dias de Oliveira, et al.
Frontiers in Medicine|November 8, 2023
In focus: perplexing increase of urinary stone disease in children, adolescent and young adult women and its economic impactGuido Filler, Sumit Dave, Victor Ritter, et al.
Journal of the American Heart Association|November 10, 2023
Who Are We Missing? Reporting of Transgender and Gender-Expansive Populations in Clinical TrialsEli N Rice, Roy H Lan, Julio C Nunes, et al.
Blood Advances|January 22, 2025
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug eraLianna J Marks, Victor Ritter, Jennifer E Agrusa, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Contemporary Clinical Trials|November 11, 2025
Trial of SiTes to IncreAse diversity in clinical TriaLs (TOTAL): A study protocol paperTenzin Yeshi Wangdak Yuthok, Anny D Rodriguez, Victor Ritter, et al.
Nature Communications|April 12, 2023
Antimicrobial exposure is associated with decreased survival in triple-negative breast cancerJulia D Ransohoff, Victor Ritter, Natasha Purington, et al.
JAMA Oncology|February 13, 2025
Endocrine Therapy Interruption, Resumption, and Outcomes Associated With Pregnancy After Breast CancerJulia D Ransohoff, Rebecca M Lewinsohn, James Dickerson, et al.
BMJ Public Health|July 7, 2025
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in BrazilJuliana Barros Verruck, Marco Antonio Moreira Puga, Roberto Dias de Oliveira, et al.
Frontiers in Medicine|November 8, 2023
In focus: perplexing increase of urinary stone disease in children, adolescent and young adult women and its economic impactGuido Filler, Sumit Dave, Victor Ritter, et al.
Journal of the American Heart Association|November 10, 2023
Who Are We Missing? Reporting of Transgender and Gender-Expansive Populations in Clinical TrialsEli N Rice, Roy H Lan, Julio C Nunes, et al.
Blood Advances|January 22, 2025
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug eraLianna J Marks, Victor Ritter, Jennifer E Agrusa, et al.
Pageof 4